Overview

R-Verapamil for the Prophylaxis of Episodic Cluster Headache

Status:
Terminated
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
This is a double-blinded, randomized, parallel, placebo-controlled phase 2 study to evaluate the safety and efficacy of R-verapamil in the prophylaxis of episodic cluster headache.
Phase:
Phase 2
Details
Lead Sponsor:
Center Laboratories, Inc.
Treatments:
Verapamil